1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF878 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA ZNF891 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA AP003419.11 CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA RUNDC3A CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA USP22 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA CCNT2 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA TRIM36 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA KIAA1143 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA SCAI CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA BOLA2B CTRPv2 pan-cancer AAC -0.14 2e-05
Download CSV